amifampridine has been researched along with Alloxan Diabetes in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Lunteren, E | 1 |
| Moyer, M | 1 |
1 other study available for amifampridine and Alloxan Diabetes
| Article | Year |
|---|---|
Streptozotocin-diabetes alters action potentials in rat diaphragm.
Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Animals; Diabetes Mellitus, Experimental; Diaphra | 2003 |